A detailed history of Tandem Capital Management Corp transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Tandem Capital Management Corp holds 20,140 shares of IART stock, worth $392,931. This represents 0.21% of its overall portfolio holdings.

Number of Shares
20,140
Previous 38,851 48.16%
Holding current value
$392,931
Previous $705,000 48.23%
% of portfolio
0.21%
Previous 0.4%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$17.14 - $31.74 $320,706 - $593,887
-18,711 Reduced 48.16%
20,140 $365,000
Q3 2024

Oct 23, 2024

BUY
$17.14 - $31.74 $201,652 - $373,421
11,765 Added 43.44%
38,851 $705,000
Q2 2024

Jul 08, 2024

SELL
$23.14 - $34.72 $272,242 - $408,480
-11,765 Reduced 30.28%
27,086 $789,000
Q4 2023

Feb 02, 2024

BUY
$34.21 - $44.59 $36,194 - $47,176
1,058 Added 2.8%
38,851 $1.69 Million
Q3 2023

Oct 30, 2023

BUY
$37.8 - $45.97 $89,964 - $109,408
2,380 Added 6.72%
37,793 $1.44 Million
Q2 2023

Aug 15, 2023

BUY
$37.95 - $58.98 $48,803 - $75,848
1,286 Added 3.77%
35,413 $1.46 Million
Q1 2023

May 04, 2023

BUY
$52.61 - $60.49 $157,830 - $181,470
3,000 Added 9.64%
34,127 $1.96 Million
Q4 2022

Jan 18, 2023

BUY
$42.17 - $58.6 $165,475 - $229,946
3,924 Added 14.42%
31,127 $0
Q3 2022

Oct 24, 2022

BUY
$42.28 - $57.17 $187,723 - $253,834
4,440 Added 19.51%
27,203 $1.17 Million
Q2 2022

Jul 19, 2022

BUY
$53.86 - $66.52 $42,280 - $52,218
785 Added 3.57%
22,763 $1.23 Million
Q1 2022

Apr 26, 2022

BUY
$62.86 - $69.24 $1.38 Million - $1.52 Million
21,978 New
21,978 $1.33 Million

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.63B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Tandem Capital Management Corp Portfolio

Follow Tandem Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tandem Capital Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Tandem Capital Management Corp with notifications on news.